Showing 1,201 - 1,220 results of 1,890 for search '"type II diabetes"', query time: 0.13s Refine Results
  1. 1201

    C-Peptide: A New Mediator of Atherosclerosis in Diabetes by Dusica Vasic, Daniel Walcher

    Published 2012-01-01
    “…In this paper we discuss the role of C-peptide and its effects in the development of atherosclerosis in type 2 diabetic patients.…”
    Get full text
    Article
  2. 1202

    Exenatide with Metformin Ameliorated Visceral Adiposity and Insulin Resistance by Xuan Du, Wen Lu, Zijun Lu, Xinyu Shao, Chunhong Hu, Bimin Shi

    Published 2018-01-01
    “…Exenatide is an ideal treatment for obese type 2 diabetic patients in the aspect of adipose tissue distribution. …”
    Get full text
    Article
  3. 1203

    Insulin Detemir Causes Lesser Weight Gain in Comparison to Insulin Glargine: Role on Hypothalamic NPY and Galanin by Mohammad Ishraq Zafar, Cuining Hu, Danfeng Liu, Raja Adeel Shafqat, Feng Gao

    Published 2014-01-01
    “…Insulin detemir decreased food intake in type 2 diabetic rats, which led to reduced weight gain when compared to insulin glargine treatment. …”
    Get full text
    Article
  4. 1204

    A High-Fat Diet Causes Impairment in Hippocampal Memory and Sex-Dependent Alterations in Peripheral Metabolism by Erica L. Underwood, Lucien T. Thompson

    Published 2016-01-01
    “…While high-fat diets are associated with rising incidence of obesity/type-2 diabetes and can induce metabolic and cognitive deficits, sex-dependent comparisons are rarely systematically made. …”
    Get full text
    Article
  5. 1205

    The Role of Insulin, Insulin Growth Factor, and Insulin-Degrading Enzyme in Brain Aging and Alzheimer's Disease by Claude Messier, Kevin Teutenberg

    Published 2005-01-01
    “…Most brain insulin comes from the pancreas and is taken up by the brain by what appears to be a receptor-based carrier. Type 2 diabetes animal models associated with insulin resistance show reduced insulin brain uptake and content. …”
    Get full text
    Article
  6. 1206

    Exenatide Treatment Causes Suppression of Serum Ghrelin Levels following Mixed Meal Test in Obese Diabetic Women by Figen Topyildiz, Sinem Kiyici, Zulfiye Gul, Deniz Sigirli, Metin Guclu, Gurcan Kisakol, Sinan Cavun

    Published 2016-01-01
    “…To investigate the effect of exenatide treatment on serum ghrelin levels in obese female patients with type 2 diabetes mellitus. Methods. Fourteen female patients with type 2 diabetes mellitus being treated with metformin and exenatide were enrolled. …”
    Get full text
    Article
  7. 1207

    The Construction of Regulatory Network for Insulin-Mediated Genes by Integrating Methods Based on Transcription Factor Binding Motifs and Gene Expression Variations by Hyeim Jung, Seonggyun Han, Sangsoo Kim

    Published 2015-09-01
    “…Type 2 diabetes mellitus is a complex metabolic disorder associated with multiple genetic, developmental and environmental factors. …”
    Get full text
    Article
  8. 1208

    Adipocytokine Associations with Insulin Resistance in British South Asians by D. R. Webb, K. Khunti, S. Chatterjee, J. Jarvis, M. J. Davies

    Published 2013-01-01
    “…Adipocytokines are implicated in the pathogenesis of type 2 diabetes and may represent identifiable precursors of metabolic disease within high-risk groups. …”
    Get full text
    Article
  9. 1209

    New Players for Advanced Prostate Cancer and the Rationalisation of Insulin-Sensitising Medication by Jennifer H. Gunter, Phoebe L. Sarkar, Amy A. Lubik, Colleen C. Nelson

    Published 2013-01-01
    “…Obesity and type 2 diabetes are recognised risk factors for the development of some cancers and, increasingly, predict more aggressive disease, treatment failure, and cancer-specific mortality. …”
    Get full text
    Article
  10. 1210

    The Relationship between Serum Ferritin and Insulin Resistance in Different Glucose Metabolism in Nonobese Han Adults by Bo-wei Liu, Xu-min Xuan, Jun-ru Liu, Fang-ning Li, Fu-Zai Yin

    Published 2015-01-01
    “…The exact mechanism through which elevated serum ferritin promotes the development of type 2 diabetes is unknown. This study showed that ferritin concentration in impaired glucose regulation and newly diagnosed diabetes mellitus subjects of nonobesity already significantly increased when compared with normal glucose tolerant subjects of nonobesity. …”
    Get full text
    Article
  11. 1211
  12. 1212

    Mediterranean Diet and Metabolic Syndrome by Josipa Radić, Marijana Vučković, Andrej Belančić, Hana Đogaš, Mislav Radić

    Published 2025-01-01
    “…MeDi, emphasizing the consumption of whole grains, fruits, vegetables, legumes, nuts, and olive oil, has been linked to a reduced risk of type 2 diabetes and improved glucoregulation. A randomized controlled trial showed that a low-carb MeDi resulted in a 30% lower relative risk of developing type 2 diabetes compared to a low-fat diet. …”
    Get full text
    Article
  13. 1213

    Effect of Pentoxifylline on Microalbuminuria in Diabetic Patients: A Randomized Controlled Trial by Shahrzad Shahidi, Marziyeh Hoseinbalam, Bijan Iraj, Mojtaba Akbari

    Published 2015-01-01
    “…Pentoxifylline has not a significant additive antimicroalbuminuric effect compared with placebo in patients with type 2 diabetes with early stage of kidney disease; however, further clinical investigations are necessary to be done.…”
    Get full text
    Article
  14. 1214

    Hypoglycemic activity of brown seaweed (Sargassum plagiophyllum) kombucha bioactive compound in rat model type-2 of diabetes by Priambodo Ahmad Faris, Martati Erryana, Firdaus Muhamad

    Published 2025-01-01
    “…This study aims to evaluate the administration of S. plagiophyllum kombucha (SK) to the blood profile of type 2 diabetes mellitus (DM2) rats treated with a 21% highfructose diet (HFD) with normal feed. …”
    Get full text
    Article
  15. 1215

    Oxidative Stress: A Link between Diabetes Mellitus and Periodontal Disease by Adriana Monea, Tibor Mezei, Sorin Popsor, Monica Monea

    Published 2014-01-01
    “…Tissue samples from ten adult patients with type 2 diabetes mellitus (T2D) and eight healthy adults were harvested. …”
    Get full text
    Article
  16. 1216

    Pharmacogenetics of Oral Antidiabetic Drugs by Matthijs L. Becker, Ewan R. Pearson, Ivan Tkáč

    Published 2013-01-01
    “…Oral antidiabetic drugs (OADs) are used for more than a half-century in the treatment of type 2 diabetes. Only in the last five years, intensive research has been conducted in the pharmacogenetics of these drugs based mainly on the retrospective register studies, but only a handful of associations detected in these studies were replicated. …”
    Get full text
    Article
  17. 1217

    Rationale and design of Diabetes Prevention with active Vitamin D (DPVD): a randomised, double-blind, placebo-controlled study by Yoshiya Tanaka, Yosuke Okada, Tetsuya Kawahara, Gen Suzuki, Tetsuya Inazu, Shoichi Mizuno, Fumiyoshi Kasagi

    Published 2016-07-01
    “…The primary end point is the cumulative incidence of type 2 diabetes. Secondary endpoint is the number of participants who achieve normoglycaemia at 48, 96 and 144 weeks. …”
    Get full text
    Article
  18. 1218

    Peroxisome Proliferator-Activated Receptors and Hepatitis C Virus-Induced Insulin Resistance by Francesco Negro

    Published 2009-01-01
    “…Insulin resistance and type 2 diabetes are associated with hepatitis C virus infection. …”
    Get full text
    Article
  19. 1219

    Diabetes and Coronary Heart Disease: A Risk Factor for the Global Epidemic by Maguy Chiha, Mario Njeim, Edgar G. Chedrawy

    Published 2012-01-01
    “…In this we will paper focus on type 2 diabetes mellitus as a risk factor for coronary heart disease, review the mechanisms of atherogenesis in diabetics, the impact of hypertension and the treatment goals in diabetics, the guidelines for screening, and review the epidemiologic consequences of diabetes and heart disease on a global scale. …”
    Get full text
    Article
  20. 1220

    The EndoBarrier: Duodenal-Jejunal Bypass Liner for Diabetes and Weight Loss by Aruchuna Ruban, Hutan Ashrafian, Julian P. Teare

    Published 2018-01-01
    “…The rapid rise of obesity and type 2 diabetes poses a global threat to healthcare and is a major cause of mortality and morbidity. …”
    Get full text
    Article